Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Journal stats
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
Clinical Research and Public Health
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
ASCI Milestone Awards
Video Abstracts
Conversations with Giants in Medicine
Reviews
Reviews
View all reviews ...
Review Series
The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
Neurodegeneration (Mar 2026)
Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
Pancreatic Cancer (Jul 2025)
Complement Biology and Therapeutics (May 2025)
Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
Microbiome in Health and Disease (Feb 2025)
View all review series ...
Viewpoint
Collections
In-Press Preview
Clinical Research and Public Health
Research Letters
Letters to the Editor
Editorials
Commentaries
Editor's notes
Reviews
Viewpoints
100th anniversary
Top read articles
Nonnutritive sweeteners and glucose intolerance: Where do we go from here?
Samuel Philip Nobs, Eran Elinav
Samuel Philip Nobs, Eran Elinav
View:
Text
|
PDF
Viewpoint
Nonnutritive sweeteners and glucose intolerance: Where do we go from here?
Text
PDF
Abstract
Authors
Samuel Philip Nobs, Eran Elinav
×
Figure 1
The possible responses to NNSs.
Options:
View larger image
(or click on image)
Download as PowerPoint
An overview of how different factors may affect the physiological impact of NNS consumption.